A detailed history of Ci Investments Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Ci Investments Inc. holds 238,909 shares of AZN stock, worth $21.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
238,909
Previous 382,356 37.52%
Holding current value
$21.4 Million
Previous $26.7 Million 31.4%
% of portfolio
0.07%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$68.72 - $82.11 $9.86 Million - $11.8 Million
-143,447 Reduced 37.52%
238,909 $18.3 Million
Q2 2025

Aug 12, 2025

SELL
$64.87 - $75.0 $12.5 Million - $14.4 Million
-192,586 Reduced 33.5%
382,356 $26.7 Million
Q1 2025

May 13, 2025

SELL
$65.37 - $77.96 $256,054 - $305,369
-3,917 Reduced 0.68%
574,942 $42.3 Million
Q4 2024

Feb 12, 2025

BUY
$63.2 - $79.58 $1.11 Million - $1.4 Million
17,630 Added 3.14%
578,859 $37.9 Million
Q3 2024

Nov 12, 2024

BUY
$76.67 - $87.62 $43 Million - $49.2 Million
561,229 New
561,229 $43.7 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $277B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Ci Investments Inc. Portfolio

Follow Ci Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.